遗传性血管的未满足需求:一项国际医生调查
Thomas Buttgereit1,2, Felix Aulenbacher3,4, Adil Adatia5
1Dermatology and Allergy, Institute of Allergology, Charité-Universitätsmedizin Berlin, Freie Universität Berlin and Humboldt-Universität Zu Berlin, Hindenburgdamm 27, 12203, Berlin, Germany. thomas.buttgereit@charite.de.
Orphanet journal of rare diseases
|July 29, 2025
概括
遗传性血管 (HAE) 管理面临着重大未满足的需求,许多患者无法实现治疗目标. 解决医生的知识差距和改善治疗机会对于优化HAE护理至关重要.
科学领域:
- 过敏和免疫学 过敏和免疫学
- 遗传学和罕见疾病
- 患者的治疗结果.
背景情况:
- 遗传性血管 (HAE) 是一种罕见的,危及生命的遗传性疾病,导致不可预测的胀发作.
- 门塔利斯特调查是第一个国际研究,旨在确定高海地未满足的需求和管理障碍.
研究的目的:
- 发现遗传性血管 (HAE) 管理中的未满足需求.
- 根据最近的指导方针更新,确定最佳HAE护理的障碍.
主要方法:
- 一个基于网络的调查,包含24个关于HAE管理和未满足需求的问题.
- HAE专家医生从他们的角度和患者的角度使用10点的利克特级别对未满足的需求进行了排名.
主要成果:
- 接受调查的近一半的HAE患者未能完全控制疾病或使生活正常化.
- 在各个地区观察到指导方针的不一致执行.
- 关键的挑战包括医生知识差距,治疗费用和预防费用补偿.
结论:
- 显著的障碍阻碍了HAE患者实现治疗目标.
- 建议采取行动,以改善治疗机会,医生和患者教育,以及利益相关方的合作,以优化HAE护理.
相关概念视频
Nephrotic Syndrome II : Assessment and Medical Management
23
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
23
Angina IV: Management
24
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
24
Angina V: Nursing Management
51
Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
51
Cardiomyopathy V: Interprofessional Care
34
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
34
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
510
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
510
Heart Failure V: Medical Management
25
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
25


